Why Children May Experience Mild COVID-19

Compared to adults, children with COVID-19 have a lower T cell response, possibly leading to mild or asymptomatic infections.

immunoscape, immunology, deep immunomics

Revolutionizing Immunology With ImmunoScape’s Deep Immunomics Platform

From cancer to COVID-19, ImmunoScape’s Deep Immunomics platform sheds new light on individual responses to treatments and vaccines, creating breakthroughs in the fight against disease.

A Triple Threat Against Cancer

A three-in-one approach combining immune checkpoint inhibition, tumor microenvironment targeting and chemotherapy drugs could help tackle difficult-to-treat tumors.

Conquering One Outbreak After Another (VIDEO)

Leading viral immunologist Professor Lisa Ng is leveraging modern tools in the age-old battle against disease-causing pathogens.

Tackling Triple Negative Breast Cancer

Targeting a cytokine called IL-34 could help patients with a drug-resistant form of breast cancer known as triple negative breast cancer.

Seeing Flow Cytometry In A Whole New Light

Combining flexibility, ease of use and sensitivity in one affordable platform, Cytek’s Biosciences Inc.’s Northern Lights flow cytometer promises to bring cell analysis within the reach of many.

Key Antibody Targets Of SARS-CoV-2 Identified

Researchers in Hong Kong have discovered that focusing on antibodies against ORF3b and ORF8 could lead to a rapid antibody test that is both highly sensitive and specific.

Mutation Making SARS-CoV-2 Milder Identified

The ∆382 mutation in the open reading frame 8 region of the SARS-CoV-2 genome leads to less severe infections and could possibly be used as a live attenuated vaccine.

How The Immune System Spots Melioidosis Bacteria

Researchers have found that cell fusion—rather than the bacteria itself—is what alerts the immune system to Burkholderia pseudomallei infection.

Tadamitsu Kishimoto Wins 2020 Tang Prize

Tadamitsu Kishimoto of Osaka University is one of three recipients of the 2020 Tang Prize in Biopharmaceutical Sciences.